Topics

12/13/19

The New York State Area Health Education Center System (AHEC), based in the Department of Family Medicine, has received two federal grants for programs aimed at addressing the opioid epidemic.

12/12/19

Eight faculty members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 16th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.

12/11/19

They spent their middle school and high school years with a firsthand view of the development of the burgeoning Buffalo Niagara Medical Campus, including the sparkling new downtown building that houses the Jacobs School of Medicine and Biomedical Sciences.

12/6/19

An abstract co-authored by Rasheen Powell, a doctoral candidate in the Department of Pharmacology and Toxicology, has been selected as a “Neuroscience 2019 Hot Topic” by the Society for Neuroscience.

12/5/19

Garwood Medical Devices, LLC, has been granted “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the company’s BioPrax device, a tool it is developing to help eliminate biofilm infections on prosthetic knee implants.

12/4/19

Twenty-five faculty members with a variety of clinical and research experience — representing eight medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.

12/3/19

Researchers at the Jacobs School of Medicine and Biomedical Sciences are attempting to prevent those with prediabetes from developing Type 2 diabetes.

12/3/19

Tracey A. Ignatowski, PhD, assistant professor of pathology and anatomical sciences, has developed a treatment for chronic pain that could have an impact in dealing with the opioid crisis.

12/3/19

University at Buffalo researchers have launched a study that combines artificial intelligence (AI) with data gathered by continuous glucose monitoring devices.

11/27/19

David Dietz, PhD, associate professor and chair of pharmacology and toxicology, is senior author on a pair of papers dealing with the study of drug relapse.

11/26/19

The nation’s first Opioid Intervention Court (OIC) was established in Buffalo in 2017 after — in a single week — three traditional drug-treatment court defendants fatally overdosed on opioids before their second court appearance.

11/21/19

According to Sanjay Sethi, MD, professor of medicine, the recent emergence of severe and even fatal vaping-related lung disease presents a challenge for health care providers and is causing some changes in their practices.

11/20/19

The difficulty of reversing obesity in adults is well known and the deleterious effects that obesity has on an individual’s health can range from diabetes to heart disease to cancer.

11/19/19

Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, received a rare, perfect score from the National Institutes of Health (NIH) on his grant application for expansion of a center designed to enhance care for older adults throughout Western New York.

11/18/19

Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, and doctoral student Brandon Ginley have developed a new method that automates the classification of progressive diabetic kidney disease, reducing variability and boosting precision.

11/18/19
Barbara Rita Alevriadou, SUNY Empire Innovation Professor, has been named the sixth associate editor of the American Journal of Physiology - Cell Physiology. The journal is among the best publications in the field of physiology.
11/15/19

The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.

11/15/19

Sixty-seven oral and poster presentations were showcased at the 13th annual Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

11/13/19

Two Jacobs School of Medicine and Biomedical Sciences’ researchers studying how to develop novel, non-addicting painkillers have each been issued awards by the Helping to End Addiction Long-term (HEAL) Initiative, a prestigious and highly competitive program from the National Institutes of Health.

11/12/19

Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.